Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
Sign Up to like & getrecommendations! Published in 2022 at "Substance abuse"
DOI: 10.1080/08897077.2021.2010162
Abstract: Access to the opioid antidote naloxone is a critical component of addressing the opioid crisis. Naloxone is a population-level prevention intervention associated with substantial reductions in overdose mortality and reduction of nonfatal overdose. Pharmacies' pivotal… read more here.
Keywords: provision; study; nonprescription; nonprescription syringes ... See more keywords
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic
Sign Up to like & getrecommendations! Published in 2023 at "Clinical Toxicology"
DOI: 10.1080/15563650.2022.2158847
Abstract: Abstract Objective To examine pediatric exposure trends involving selected nonprescription analgesics/antipyretics, before and during the COVID-19 pandemic. Methods Using descriptive and interrupted time-series analyses, we assessed monthly United States poison center data involving pediatric ( read more here.
Keywords: antipyretic exposures; nonprescription; nonprescription analgesic; analgesic antipyretic ... See more keywords